ScoreWhy is Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 9.49% and Operating profit at 6.57% over the last 5 years
2
Flat results in Mar 26
- INTEREST(HY) At CNY 0.43 MM has Grown at 11.73%
- DEBT-EQUITY RATIO (HY) Highest at -47.67 %
- INVENTORY TURNOVER RATIO(HY) Lowest at 0.79 times
3
With ROE of 14.93%, it has a fair valuation with a 3.60 Price to Book Value
- Over the past year, while the stock has generated a return of 12.59%, its profits have risen by 36.3% ; the PEG ratio of the company is 0.7
- At the current price, the company has a high dividend yield of 1.2
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.
-29.18%
0.13
41.23%
China Shanghai Composite
3.23%
1.20
14.07%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
9.49%
EBIT Growth (5y)
6.57%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.53
Sales to Capital Employed (avg)
0.39
Tax Ratio
14.01%
Dividend Payout Ratio
34.36%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
33.71%
ROE (avg)
15.88%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
27
Industry P/E
Price to Book Value
4.07
EV to EBIT
23.60
EV to EBITDA
21.35
EV to Capital Employed
6.91
EV to Sales
9.05
PEG Ratio
0.75
Dividend Yield
1.03%
ROCE (Latest)
29.30%
ROE (Latest)
14.93%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend10What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 417.3 MM
ROCE(HY)
Highest at 15.98%
INVENTORY TURNOVER RATIO(HY)
Highest at 1.92 times
RAW MATERIAL COST(Y)
Fallen by 1.09% (YoY
CASH AND EQV(HY)
Highest at CNY 2,778.13 MM
DEBTORS TURNOVER RATIO(HY)
Highest at 3.91 times
-2What is not working for the Company
DEBT-EQUITY RATIO
(HY)
Highest at -52.09 %
Here's what is working for Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.
Operating Cash Flow
Highest at CNY 417.3 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Inventory Turnover Ratio
Highest at 1.92 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Cash and Eqv
Highest at CNY 2,778.13 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debtors Turnover Ratio
Highest at 3.91 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by 1.09% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.
Debt-Equity Ratio
Highest at -52.09 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Footer loading
